Mesenchymal Stem Cell Treatment for Patients Infected With 2019 Novel Coronavirus

The 2019 novel coronavirus (2019-nCoV) infection caused clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus and was associated with ICU admission and high mortality.

Scientific data in relation to stem cell treatments are promising regarding the healing abilities of UC-MS due to the immunomodulation and regenerative potential of these cells.

The trial is in progress.